BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17240971)

  • 1. Cryptophycin anticancer drugs revisited.
    Rohr J
    ACS Chem Biol; 2006 Dec; 1(12):747-50. PubMed ID: 17240971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthetic characterization and chemoenzymatic assembly of the cryptophycins. Potent anticancer agents from cyanobionts.
    Magarvey NA; Beck ZQ; Golakoti T; Ding Y; Huber U; Hemscheidt TK; Abelson D; Moore RE; Sherman DH
    ACS Chem Biol; 2006 Dec; 1(12):766-79. PubMed ID: 17240975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoenzymatic synthesis of cryptophycin/arenastatin natural products.
    Beck ZQ; Aldrich CC; Magarvey NA; Georg GI; Sherman DH
    Biochemistry; 2005 Oct; 44(41):13457-66. PubMed ID: 16216069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total synthesis of cryptophycin analogues via a scaffold approach.
    McCubbin JA; Maddess ML; Lautens M
    Org Lett; 2006 Jul; 8(14):2993-6. PubMed ID: 16805535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short and efficient synthesis of cryptophycin unit A.
    Eissler S; Nahrwold M; Neumann B; Stammler HG; Sewald N
    Org Lett; 2007 Mar; 9(5):817-9. PubMed ID: 17284043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, conformational analysis, and cytotoxicity of new analogues of the natural cyclodepsipeptide jaspamide.
    Terracciano S; Bruno I; Bifulco G; Copper JE; Smith CD; Gomez-Paloma L; Riccio R
    J Nat Prod; 2004 Aug; 67(8):1325-31. PubMed ID: 15332850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and cytotoxicity of a new class of potent decapeptide macrocycles.
    Davis MR; Styers TJ; Rodriguez RA; Pan PS; Vasko RC; McAlpine SR
    Org Lett; 2008 Jan; 10(2):177-80. PubMed ID: 18095697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total synthesis and antitubulin activity of c10 analogues of cryptophycin-24.
    Buck SB; Huff JK; Himes RH; Georg GI
    J Med Chem; 2004 Jan; 47(3):696-702. PubMed ID: 14736249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total synthesis of sandramycin and its analogues via a multicomponent assemblage.
    Katayama K; Nakagawa K; Takeda H; Matsuda A; Ichikawa S
    Org Lett; 2014 Jan; 16(2):428-31. PubMed ID: 24341513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First generation design, synthesis, and evaluation of azepine-based cryptophycin analogues.
    Smith AB; Cho YS; Zawacki LE; Hirschmann R; Pettit GR
    Org Lett; 2001 Dec; 3(25):4063-6. PubMed ID: 11735585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient synthesis of cryptophycin-52 and novel para-alkoxymethyl unit A analogues.
    Eissler S; Bogner T; Nahrwold M; Sewald N
    Chemistry; 2009 Oct; 15(42):11273-87. PubMed ID: 19760734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antitumor activity of cyclodepsipeptide zygosporamide and its analogues.
    Wang Y; Zhang F; Zhang Y; Liu JO; Ma D
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4385-7. PubMed ID: 18606540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress of the synthetic studies of biologically active marine cyclic peptides and depsipeptides.
    Hamada Y; Shioiri T
    Chem Rev; 2005 Dec; 105(12):4441-82. PubMed ID: 16351050
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and cytotoxicity studies of new cryptophycin analogues.
    Liu WL; Zhang JC; Jiang FQ; Fu L
    Arch Pharm (Weinheim); 2009 Oct; 342(10):577-83. PubMed ID: 19714674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Halohydrin analogues of cryptophycin 1: synthesis and biological activity.
    Georg GI; Ali SM; Stella VJ; Waugh WN; Himes RH
    Bioorg Med Chem Lett; 1998 Aug; 8(15):1959-62. PubMed ID: 9873466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depsipeptide synthesis.
    Stawikowski M; Cudic P
    Methods Mol Biol; 2007; 386():321-39. PubMed ID: 18604953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors.
    Liang J; Moore RE; Moher ED; Munroe JE; Al-awar RS; Hay DA; Varie DL; Zhang TY; Aikins JA; Martinelli MJ; Shih C; Ray JE; Gibson LL; Vasudevan V; Polin L; White K; Kushner J; Simpson C; Pugh S; Corbett TH
    Invest New Drugs; 2005 Jun; 23(3):213-24. PubMed ID: 15868377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of cryptothilone 1, the first cryptophycin-epothilone hybrid.
    White JD; Smits H; Hamel E
    Org Lett; 2006 Aug; 8(18):3947-50. PubMed ID: 16928045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient solid-phase synthesis of FK228 analogues as potent antitumoral agents.
    Di Maro S; Pong RC; Hsieh JT; Ahn JM
    J Med Chem; 2008 Nov; 51(21):6639-41. PubMed ID: 18839938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The first biologically active synthetic analogues of FK228, the depsipeptide histone deacetylase inhibitor.
    Yurek-George A; Cecil AR; Mo AH; Wen S; Rogers H; Habens F; Maeda S; Yoshida M; Packham G; Ganesan A
    J Med Chem; 2007 Nov; 50(23):5720-6. PubMed ID: 17958342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.